000 01186 a2200313 4500
005 20250515040355.0
264 0 _c20070301
008 200703s 0 0 eng d
022 _a0923-7534
024 7 _a10.1093/annonc/mdl181
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBerruti, A
245 0 0 _aManagement of the side-effects of intravenous bisphosphonates: targeting the serum parathyroid hormone elevation.
_h[electronic resource]
260 _bAnnals of oncology : official journal of the European Society for Medical Oncology
_cDec 2006
300 _a1854-5 p.
_bdigital
500 _aPublication Type: Comment; Letter
650 0 4 _aDiphosphonates
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aHypocalcemia
_xchemically induced
650 0 4 _aParathyroid Hormone
_xblood
700 1 _aTucci, M
700 1 _aGenerali, D
700 1 _aMosca, A
700 1 _aArdine, M
700 1 _aVana, F
700 1 _aDogliotti, L
773 0 _tAnnals of oncology : official journal of the European Society for Medical Oncology
_gvol. 17
_gno. 12
_gp. 1854-5
856 4 0 _uhttps://doi.org/10.1093/annonc/mdl181
_zAvailable from publisher's website
999 _c16521834
_d16521834